To investigate the clinical manifestation, imaging features, pathological characteristics, and diagnosis of hepatic follicular dentritic cell sarcoma, a case report combined with literature review was introduced. A large single mass in liver was showed in CT scan. Enhanced CT showed obvious uneven change of liver neoplasm during the arterial phase and the portal vein phase with tortuous disorganized blood vessels. Immumohistochemical staining of CD21, CD23 and EBER was positive. HFDCS is extremely rare. Except for pathologicaldiagnosis by liver biopsy, its preoperative diagnosis rate is extremely low. Its diagnosis is based on the histopathology and immumohistochemistry. HFDCS was first reported by Shek in 1996, and often occurred in women aged 19 -82 years (with an average age of 46.7 years). Its main clinical manifestations were abdominal pain, abdominal distention, weight loss, anemia, fever, etc. Some patients were asymptomatic.
Introduction
The follicular dendritic cell (FDC) belongs to the immune auxiliary system and is an antigen-presenting cell with the strongest known function in the body. Its main functions are antigen capture, processing and presentation, and stimulating T lymphocytes for proliferation and differentiation. Follicular dendritic cell sarcoma (FDCS) is a low-grade malignancy with an extremely low morbidity that is formed by excessive proliferation of follicular dendritic cells and can occur in any organ except the brain. Therefore, hepatic follicular dendritic cell sarcoma (HFDCS) is extremely rare and often reported as individual cases. The whose case is reported herein.
Case Presentation
A 52-year-old male was admitted in August 2015 due to a huge liver neoplasm found during a physical examination. The patient had sought medical advice at a hospital in Beijing and was diagnosed with follicular dendritic cell sarcoma (FDCS) by liver biopsy pathology. In order to receive further operative treatment, he was admitted to the hepatobiliary surgery department of our hospital.
Since the onset, the patient was mentally normal with normal urination and defecation, and had no fever. He lost about 10 KG in nearly eight months. The past had been healthy, denying a history of hypertension and coronary heart disease, denying diabetes history, denying residential history in affected areas. Physical examination showed abdominal distention without gastrointestinal type or pe- 
Discussion
The follicular dendritic cell (FDC) belongs to the immune auxiliary system and is an antigen-presenting cell with the strongest known function in the body. Its The invasion of HFDCS is extremely rare, so its treatment is limited and no treatment guideline can be used as a reference. As it usually manifests inertly and is similar to soft tissue sarcoma of low to mid malignancy, tumors of most patients can be completely resected in combination with postoperative chemotherapy or radiotherapy. Chemotherapy is also given to patients who are unable to or refuse surgery. Most of them are treated with a combined regimen based on the Non-Hodgkin lymphoma chemotherapy regimen, namely the CHOP regimen (a 21-day cycle of ifosfamide injection, epirubicin injection, vincristine injection and prednisone) for 3 -6 cycles. Pas [10] et al. performed a retrospectiveanalysis of 184 FDCS cases, and showed that the recurrencerate of patients who received an excision without any adjuvant therapy was 40%, while that of patients who received an excision with adjuvant therapy was 32.6% indicating that chemotherapy and radiotherapy did not enhance the postoperative survival rate of patients.
Conclusion
In conclusion, HFDCS is extremely rare. Except for pathological diagnosis by liver biopsy, its preoperative diagnosis rate is extremely low. A tumor diameter > 6 cm is considered to be an important factor for poor prognosis. In this case, with liver biopsy before the surgery, the patient had a clear pathological diagnosis and the tumor diameter was >6 cm. After partial hepatectomy, the patient was admitted to a local hospital for sequential treatment. The patient's condition is currently stable. During outpatient reexamination at our hospital, no metastasis or recurrence was observed in enhanced CT of the abdomen. The patient has not yet received radiotherapy or chemotherapy. Further follow-up is needed for long-term prognosis.
